by Ted Rogers Centre for Heart Research | Apr 8, 2020 | Equitable Access to Care, Personalized Medicine, Translating Innovation, Why Heart Failure
Medly cuts re-hospitalizations for heart failure by 50%
by Ted Rogers Centre for Heart Research | Feb 12, 2020 | Equitable Access to Care, Personalized Medicine, Why Heart Failure
Direct translation from research to clinic
by Ted Rogers Centre for Heart Research | Jan 28, 2020 | Education & Training, Events, Why Heart Failure
All welcome to attend Feb. 19th workshop in Toronto
by Ted Rogers Centre for Heart Research | Nov 20, 2019 | Education & Training, Equitable Access to Care, Funding Opportunities, Investigating Heart Failure, Personalized Medicine, Translating Innovation, Why Heart Failure
The promise of a record gift is coming to fruition
by Ted Rogers Centre for Heart Research | Nov 11, 2019 | Equitable Access to Care, Personalized Medicine, Translating Innovation, Why Heart Failure
Medly is the future of heart failure care
by Ted Rogers Centre for Heart Research | Oct 23, 2019 | Events, Why Heart Failure
New art workshop for heart patients opens Nov. 18
by Ted Rogers Centre for Heart Research | Aug 23, 2019 | Personalized Medicine, Why Heart Failure
New study aims to change screening guidelines
by Ted Rogers Centre for Heart Research | Jul 2, 2019 | Equitable Access to Care, Why Heart Failure
Less access to specialists may increase readmission risk
by Ted Rogers Centre for Heart Research | Jun 11, 2019 | Investigating Heart Failure, Personalized Medicine, Why Heart Failure
PIONEER 6 finds novel GLP-1 RA is safe for the heart
by Ted Rogers Centre for Heart Research | Apr 1, 2019 | Education & Training, Equitable Access to Care, Funding Opportunities, Investigating Heart Failure, Personalized Medicine, Translating Innovation, Why Heart Failure
Collaborative Ted Rogers Centre has taken new aim at heart failure